Skip to content
10-K

Annual Report

TONGLI PHARMACEUTICALS (USA), INC.

0001144204-12-039586

← back to feed
Filed
Jul 16, 2012 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2011 · Jun 27, 2012 13.55M sh
Operating Cash Flow FY 2011 · Mar 31, 2011 $5.78M
Current Liabilities FY 2011 · Mar 31, 2011 $1.79M
Current Assets FY 2011 · Mar 31, 2011 $3.98M
Total Assets FY 2011 · Mar 31, 2011 $17.87M
Sga Expense FY 2011 · Mar 31, 2011 $613.61K
Net Income FY 2011 · Mar 31, 2011 $4.26M
Operating Income FY 2011 · Mar 31, 2011 $5.88M
Gross Profit FY 2011 · Mar 31, 2011 $6.92M
Cost Of Revenue FY 2011 · Mar 31, 2011 $7.73M
Stockholders Equity FY 2011 · Mar 31, 2010 $10.06M